Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

  1. Home
  2. PAAB Q&A
  3. CME, educational material, Reprints, reports, textbooks, independently created content
  4. 69 - The CFPC has reviewed and approved a program for Mainpro-M1 credits and is awaiting final accreditation by the College's provincial chapter. Are materials used within the program (e.g. Slide Kit) exempt from PAAB review in the following cases: • Case 1 - Distributed to participants at the accredited event or at a later date? • Case 2 - Distributed to non-participants by sales reps?
PAAB Notice
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.

69 - The CFPC has reviewed and approved a program for Mainpro-M1 credits and is awaiting final accreditation by the College's provincial chapter. Are materials used within the program (e.g. Slide Kit) exempt from PAAB review in the following cases: • Case 1 - Distributed to participants at the accredited event or at a later date? • Case 2 - Distributed to non-participants by sales reps?

Scheduled Pinned Locked Moved CME, educational material, Reprints, reports, textbooks, independently created content
1 Posts 1 Posters 200 Views
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • Jennifer CarrollJ Offline
    Jennifer CarrollJ Offline
    Jennifer Carroll
    wrote on last edited by
    #1

    Case 1 - Materials would be considered exempt from PAAB review only after the program has received final accreditation (i.e. once you have received approval for the statement "This program has been accredited by The College of Family Physicians of Canada, and the _____ Chapter, for up to ___ Mainpro-M1 credits"), and the distribution is restricted to registrants of the event (at the event or at a later date) (see Code section 6.6a1). You should also consult the Innovative Medicines Code of Conduct.

    Case 2 –If materials are to be distributed after the event to non-participants of the event by a sponsor company, and product or therapeutic claims, comparative data or statements regarding the sponsors products are included, the complete document must be submitted to the PAAB for review (see Code section 6.6a2).

    Relevant PAAB Code sections:

    6.6(a) 1 Materials that are created by the academic organizers of accredited Continuing Education events/activities may be distributed at the event or to the registrants of that meeting at a later date.

    6.6(a) 2 If materials are to be distributed after the event to non-participants of the event by a sponsor company, and product or therapeutic claims, comparative data or statements regarding the sponsors products are included, the complete document must be submitted to the PAAB for review. The respective roles of the authors and the sponsoring pharmaceutical company must be stated clearly on the title page.

    1 Reply Last reply
    0
    Reply
    • Reply as topic
    Log in to reply
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes


    • Login

    • Don't have an account? Register

    • Login or register to search.
    • First post
      Last post
    0
    • Categories
    • Recent
    • Tags
    • Popular
    • Users
    • Groups